Trial Details
TERMINATEDBasic Information
| Clinical ID | c4740 |
|---|---|
| Identifier | NCT00038922 |
| Trial Title | Study Evaluating rhIL-11 in Left-Sided Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis|Inflammatory Bowel Disease |
| Interventions | DRUG: rhIL-11 |
Participant Information
| Sponsor | Wyeth is now a wholly owned subsidiary of Pfizer |
|---|---|
| City | NULL |
| Country/Region | NULL |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | NULL |
|---|---|
| Primary Completion Date | NULL |
| Completion Date | NULL |